Torrealba et al. analyzed CD8+ T cells in 17 SS patients before the initiation of treatment and found an increased expression of CD38 mainly in effector/memory cells, which correlated with the chronic activation status of CD8+ T cells in SS patients compared to the control [37]. The gene discussed is CD38; the disease is synovial sarcoma.